Routes of
administration Oral CAS Number 3563-49-3 UNII VOU69C02JP Pubchem 14373 ChemSpider ID 13733 | ATC code none PubChem CID 14373 Molar mass 245.36 g/mol ChEMBL ID 201960 | |
 | ||
Legal status AU: S4 (Prescription only)
CA: Schedule IV
DE: Anlage II (Prohibited)
UK: Class C
US: Schedule V | ||
What does pyrovalerone mean
Pyrovalerone (Centroton, 4-Methyl-β-keto-prolintane, Thymergix, O-2371) is a psychoactive drug with stimulant effects via acting as a norepinephrine-dopamine reuptake inhibitor (NDRI), and is used for the clinical treatment of chronic fatigue or lethargy and as an anorectic or appetite suppressant for weight loss purposes. It was developed in the late 1960s and has since been used in France and several other European countries, and although pyrovalerone is still occasionally prescribed, it is used infrequently due to problems with abuse and dependence. It is closely related on a structural level to a number of other stimulants, such as MDPV and prolintane (Promotil, Katovit).
Contents
Side effects of pyrovalerone include anorexia or loss of appetite, anxiety, fragmented sleep or insomnia, and trembling, shaking, or muscle tremors. Withdrawal following abuse upon discontinuation often results in depression.
The R-enantiomer of pyrovalerone is devoid of activity.